Levine Cancer Institute 3rd Annual Symposium on Hematologic Malignancies

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses, Licensed Practical Nurses

Description

The LCI 3rd Annual Symposium on Hematologic Malignancies will provide updates in the latest diagnostic procedures and cutting edge treatments of malignant hematologic disorders and help improve participants understanding of how to incorporate newly approved drugs in current practice. Experts in the field of Myeloma, Lymphoma, Myeloproliferative Neoplasms (MPN's), and Blood & Marrow Transplantation will present the latest findings in all aspects along with information regarding the role of stem cell transplantation in the cure of these malignancies.

Agenda
7:30 - 8:00   Registration/Breakfast
8:00 - 8:30   Welcome
8:30 - 9:15   Advances in AML, transplant and nontransplant - Fred Appelbaum, MD; University of Washington School of Medicine
9:15 - 10:00   Immune-based Treatment Approaches in Lymphoma - Leo Gordon, MD; Northwestern University Feinberg School of Medicine
10:00 - 10:15   Break
10:15 - 11:00   Pathongenesis of LGL Leukemia - Thomas Loughran Jr., MD; University of Virginia Cancer Centerne
11:00 - 12:00   Lunch - Panel Discussion and Case Studies
12:00 - 12:45   Role of Transplant with Emerging Therapies in Multiple Myeloma - Parameswaran Hari, MD, MRCP, MS; Medical College of Wisconsin
12:45 - 1:00   Closing Remarks
1:00 - 2:00   Tours (optional)

Accreditation Statement
Carolinas HealthCare System/Charlotte AHEC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement
The Carolinas HealthCare System/Charlotte AHEC designates this Live Activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

CEU Statement
This Live Activity fulfills the requirement of 0.40 Continuing Education Units (CEU's), representing 4.0 contact hours.

*No partial credit will be awarded for CEUs and/or Contact Hours*

Location
Levine Cancer Institute - Carolinas HealthCare System
3rd Floor Conference Room 3035ABC
1021 Morehead Medical Drive
Charlotte, NC 28204

By registering for the program, you authorize Charlotte AHEC to release your name, city and state to attending commercial supporters. Please contact the program support listed below if you have any questions or concerns.

Objectives

  • Define standards of care, assess and improve patient management and perform the application of recently approved therapies for patients diagnosed with hematologic malignancies such as Myeloma, Lymphoma, Myeloproliferative Neoplasms, and Blood & Marrow Transplantation
  • Identify and perform diagnostic advances and procedures for patients diagnosed with hematologic malignancies such as Myeloma, Lymphoma, Myeloproliferative Neoplasms, and Blood & Marrow Transplantation
  • Identify and incorporate newly approved agents in the treatment of Myeloma, Lymphoma, Myeloproliferative Neoplasms,and Blood & Marrow Transplantation

Contact

Rachel Clampitt, BS, 704-512-6578

Sessions

Sep 16, 2017
8:00 AM - 2:00 PM
Status
Open
Date(s)
Sep 16, 2017
Time
8:00 AM - 2:00 PM
Check-In Time
7:30 AM
Credit
4.00 - AMA PRA Category 1 Credit
0.40 - CEU
Details
Status
Open
Date(s)
Sep 16, 2017
Time
7:30 AM - 1:00 PM
Fees
$2,500.00
Exhibitor/Sponsor Fee
$75.00
Physician (MD, DO)
$50.00
Advanced Clinical Practitioner (NP, PA, PharmD)
$50.00
Nurse (RN, LPN)
$50.00
Intern/Resident
Credits
0.40
CEU
4.00
AMA PRA Category 1 Credit